← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2014Last known activity
May 1, 2024
Timeline
1900s
- Jan 1, 1902
Yangzhou University— Founded
Drugs by trial phase (25 distinct, 39 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (14 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT06517069Sponsor investigatorN/AMay 1, 2024
- NCT06517069Lead sponsorN/AMay 1, 2024
- NCT06520306Lead sponsorN/AMar 15, 2024
- NCT06520306Sponsor investigatorN/AMar 15, 2024
- NCT06118034CollaboratorPhase 3Jan 1, 2024
- NCT06284941Sponsor investigatorN/AJun 20, 2023
- NCT06284941Lead sponsorN/AJun 20, 2023
- NCT05811221Reponsible party - principal investigatorN/AApr 2, 2023
- NCT05811221Lead sponsorN/AApr 2, 2023
- NCT05809804Reponsible party - principal investigatorN/AApr 1, 2023
- NCT05809804Lead sponsorN/AApr 1, 2023
- NCT06237478Sponsor investigatorN/AMar 1, 2023
- NCT05754762Lead sponsorN/AMar 1, 2023
- NCT05754762Reponsible party - principal investigatorN/AMar 1, 2023
- NCT05909696Lead sponsorN/AMar 1, 2023
Details
- Founded
- Yangzhou, CN Jan 1, 1902
- Last known activity
- May 1, 2024